IW-3718: Phase IIa data

Top-line data from a double-blind, U.S. Phase IIa trial in 93 patients with refractory GERD who were taking a proton pump inhibitor (PPI) and continued to experience frequent GERD symptoms showed that twice-daily

Read the full 334 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE